Document is current

Any future updates will be listed below

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

Crossref DOI link: https://doi.org/10.1186/s12885-016-2052-4

Published Online: 2016-01-15

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark